TWO Probiotic

BePure TWO Probiotic is New Zealand's own advanced daily probiotic — formulated by Ben Warren and the BePure team to deliver 30 billion viable bacteria across 19 carefully selected probiotic strains in each daily serving. The formula is built around both diversity and specificity: the strain selection spans multiple bacterial genera (Lactobacillus, Bifidobacterium, Bacillus, Streptococcus, and Saccharomyces), providing broad-spectrum support for the gut microbiome alongside targeted clinical strains with supporting research.

Slow-Release Capsule Delivery The capsule technology is a meaningful differentiator. BePure TWO uses a slow-release vegetable capsule engineered to take approximately two hours to break down — allowing the probiotic bacteria to survive passage through the acidic stomach environment and reach the lower gastrointestinal tract, where they are most active, intact. Standard capsules can begin breaking down within minutes of ingestion, exposing bacteria to gastric acid before they reach their target site. The slow-release design meaningfully improves the viable delivery of sensitive strains to the intestinal environment where colonisation and beneficial activity occurs.

The Probiotic Strains The 19-strain formula covers the key genera most relevant to gastrointestinal and systemic health:

The Lactobacillus species form the backbone of the formula — including L. acidophilus, L. rhamnosus, L. plantarum, L. casei, L. paracasei, L. salivarius, L. helveticus, L. gasseri, L. reuteri, L. fermentum, and L. delbrueckii ssp. bulgaricus — collectively supporting a broad range of gut mucosal functions, including competitive exclusion of pathogenic bacteria, lactic acid production, mucus layer maintenance, and immune modulation at the intestinal epithelium.

The Bifidobacterium species — including B. lactis, B. infantis, B. breve, B. bifidum, and B. longum — are the dominant beneficial bacteria of the large intestine and are particularly associated with healthy immune development, bowel regularity, and the fermentation of prebiotic fibres into short-chain fatty acids (SCFAs) that nourish colonocytes and maintain healthy gut barrier function.

LactoSpore® (Bacillus coagulans MTCC 5856) is a clinically researched, spore-forming probiotic strain from Sabinsa Corporation. Because it exists in a dormant spore state until it reaches the intestinal environment, it is exceptionally resistant to heat, stomach acid, and bile — making it one of the most reliably deliverable probiotic organisms in any formulation. Multiple clinical trials with this specific strain have demonstrated benefits for gastrointestinal comfort, bowel function, and immune markers.

Saccharomyces boulardii (MAK08S06B) is a probiotic yeast rather than a bacterial species, which gives it a uniquely complementary profile — it is not affected by antibacterial interventions and survives antibiotic courses intact. S. boulardii has an extensive evidence base for supporting bowel function during and after antibiotic use, traveller's diarrhoea, and general gastrointestinal resilience.

Integrated Prebiotic and Gut Nourishment Complex Each serving also provides a supporting complex of:

• Inulin (FOS) 200mg — a fructooligosaccharide prebiotic that selectively feeds Bifidobacterium and Lactobacillus species, helping the probiotic bacteria establish and thrive in the gut
• Apple Pectin 24mg — a soluble dietary fibre with prebiotic properties and additional gut barrier-supporting effects
• L-Glutamine 40mg — the primary fuel source for intestinal epithelial cells, supporting gut mucosal integrity and healthy tight junction function

Together, these additions make BePure TWO a genuinely synbiotic formula — combining probiotic organisms with the prebiotic substrate they need to colonise effectively — rather than a standalone probiotic product.

The formula is shelf-stable (refrigeration not required), free from gluten, soy, corn, refined sugar, GMOs, and artificial additives, and is suitable for use during pregnancy and breastfeeding.

What Sets This Product Apart

BePure TWO stands apart through the combination of strain breadth (19 strains across five genera), clinical dose (30 billion CFU per serving), slow-release capsule delivery, the inclusion of the clinically validated LactoSpore® strain, and the integrated prebiotic/L-glutamine complex — all in a shelf-stable NZ-made product that requires no refrigeration. Most mass-market probiotics offer 2–5 strains at far lower doses in standard dissolution capsules, without prebiotic support. The slow-release capsule technology in particular addresses one of the most common failure points of probiotic supplementation — inadequate delivery of viable organisms to the distal gastrointestinal tract.

Ingredients

Per 2 capsule serving (30 billion CFU minimum):

Additional ingredients per serving: L-Glutamine 40mg, Inulin (FOS) 200mg, Apple Pectin 24mg. Other ingredients: Cellulose (capsule), vegetable stearate, silicon dioxide.

Directions for Use

Adults (12+): Take 2 capsules daily on an empty stomach — one 30 minutes before your first meal, and one 2 hours after your last meal of the day. If new to BePure TWO, begin with 1 capsule daily and increase gradually to the full dose over one to two weeks.

Children (6–11): 1 capsule daily. Capsules may be opened and mixed into food or a cool beverage if swallowing is difficult.

Take away from coffee, tea, and alcohol for best results. Store below 25°C in a cool, dry place away from direct sunlight. Refrigeration is not required, but it will not harm the product.

Allergen Information

Free from gluten, soy, corn, refined sugar, GMOs, and artificial colours, flavours, and additives. Vegetarian suitable.

Important: Probiotic strains were cultured in a dairy medium — the product does not contain dairy but may contain trace amounts of lactose due to the production process. Not recommended for individuals with a confirmed lactose allergy or high dairy sensitivity.

Not suitable for those with a yeast intolerance or allergy due to the inclusion of Saccharomyces boulardii.

Cautions: Consult your healthcare practitioner before use if you have significant gastrointestinal conditions, including Crohn's disease, ulcerative colitis, active H. pylori infection, peptic ulcers, Barrett's oesophagus, diverticulitis, SIBO, or SIFO. Safe for use during pregnancy and breastfeeding. Some individuals may experience transient changes in bowel motions (loose stools) when first commencing — this typically resolves within one to two weeks of consistent use. Keep out of reach of children.

Practitioner Note

Recommended by Stephen Roigard, Naturopath & Clinical Nutritionist. BePure TWO is a reliable, well-composed, NZ-native probiotic suitable for broad clinical use as a daily microbiome maintenance product. The 19-strain formula with 30 billion CFU is appropriate for general gut health support, post-antibiotic microbiome restoration, immune modulation, and patients with digestive irregularity. The inclusion of LactoSpore® (B. coagulans MTCC 5856) adds a clinically robust, acid-resistant strain that delivers predictably regardless of stomach pH — useful for patients with gastric acid-related concerns about probiotic viability. The S. boulardii content makes this particularly valuable for antibiotic co-prescription and travel scenarios, but contraindicates use in yeast-sensitive patients. The slow-release capsule delivery and integrated prebiotic/L-glutamine complex are genuine clinical value-adds over standard probiotic products at comparable price points. For patients with significant gut dysbiosis or pathology (SIBO, SIFO, IBD), direct them to consult prior to commencing — the 19-strain diversity may transiently aggravate symptoms in sensitive presentations, and dose titration from 1 capsule daily is the appropriate starting protocol.

This product is a dietary supplement intended to support general health and well-being. It is not intended to diagnose, treat, cure, or prevent any medical condition. Dietary supplements should not replace a balanced diet. If symptoms persist or worsen, consult a qualified healthcare practitioner.